Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 83840 refers to a laboratory test specifically designed to measure the levels of methadone in various biological samples, including blood, urine, or meconium stool. Methadone is classified as a synthetic opioid, which means it is a man-made substance that mimics the effects of natural opiates. It is primarily utilized in the management of moderate to severe chronic pain and plays a crucial role in treating individuals undergoing withdrawal from other opiate drugs. The testing process involves obtaining a sample, which can be collected through venipuncture for blood, or through a random voided urine sample, or from meconium stool collected from a newborn's diaper. The analysis of these samples is conducted using a sophisticated technique known as quantitative liquid chromatography-tandem mass spectrometry, which allows for precise measurement of methadone levels in the tested specimens. This test is essential for monitoring therapeutic levels of methadone in patients, ensuring effective pain management, and preventing potential overdose or withdrawal symptoms.
© Copyright 2026 Coding Ahead. All rights reserved.
The methadone test (CPT® Code 83840) is indicated for several specific clinical scenarios, particularly in the context of pain management and substance use treatment. The following conditions warrant the performance of this test:
The procedure for testing methadone levels involves several key steps, each critical to ensuring accurate results. The following outlines the procedural steps involved:
After the methadone testing procedure is completed, the samples are analyzed, and results are typically available within a specified timeframe, depending on the laboratory's processing capabilities. Healthcare providers will review the results to assess the methadone levels in the patient's system. Based on these results, further clinical decisions may be made regarding the patient's treatment plan, including adjustments to methadone dosage or additional interventions if necessary. It is important for healthcare professionals to communicate the results to the patient and discuss any implications for their ongoing treatment and care.
| Short Descr | ASSAY OF METHADONE | Medium Descr | METHADONE | Long Descr | Methadone | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Deleted | Code deleted, see 80358 |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.